Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells

Journal of Ethnopharmacology

Volumn 122, Issue 3, 2009, Pages 502-508

  Liu, Hao ^a,b   Wei, Wei ^a   Sun, Wu yi ^a   Li, Xiang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

Astragaloside IV; Hepatic stellate cells; Liver fibrosis; Porcine serum; Transforming growth factor 1

Indexed keywords

ASTRAGALOSIDE IV; HYALURONIC ACID; HYDROXYPROLINE; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HUMAN; LIVER FIBROSIS; LIVER FUNCTION; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STELLATE CELL; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ANIMALS; ASTRAGALUS PLANT; BODY WEIGHT; COLLAGEN; COLLAGEN TYPE III; HEPATIC STELLATE CELLS; HUMANS; HYALURONIC ACID; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SAPONINS; TRANSFORMING GROWTH FACTOR BETA1; TRITERPENES;

ASTRAGALUS MEMBRANACEUS; RATTUS; SUS;

EID: 63849283016     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.01.035     Document Type: Article

References (31)

1. Acharya S.K., and Batra Y. Is cirrhosis of the liver reversible? The ultimate that a hepatologist wishes. Tropical Gastroenterology 24 (2003) 1-2
2. Baba Y., Saeki K., Onodera T., and Doi K. Serological and immunohistochemical studies on porcine-serum-induced hepatic fibrosis in rats. Experimental and Molecular Pathology 79 (2005) 229-235
3. Bataller R., and Brenner D.A. Liver fibrosis. The Journal of Clinical Investigation 115 (2005) 209-218
4. Bedossa P., and Paradis V. Liver extracellular matrix in health and disease. The Journal of Pathology 200 (2003) 504-515
5. Beljaars L., Meijer D.K., and Poelstra K. Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis. Frontiers in Bioscience 7 (2002) 214-222
6. Benyon R.C., Hovell C.J., Da Gaça M., Jones E.H., Iredale J.P., and Arthur M.J. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30 (1999) 977-986
7. Bhunchet E., and Fujieda K. Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow. Hepatology 18 (1993) 1450-1458
8. Casini A., Ceni E., Salzano R., Schuppan D., Milani S., Pellegrini G., and Surrenti C. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 105 (1993) 245-253
9. Chen X.J., Meng D., Feng L., Bian Y.Y., Li P., Yang D., Cao K.J., and Zhang J.N. Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats. The American Journal of Chinese Medicine 34 (2006) 1015-1025
10. Dooley S., Hamzavi J., Breitkopf K., Wiercinska E., Said H.M., Lorenzen J., Ten Dijke P., and Gressner A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 (2003) 178-191
11. Friedman S.L. Liver fibrosis-from bench to bedside. Journal of Hepatology 38 Suppl. 1 (2003) S38-53
12. Friedman S.L. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology 40 (2004) 1041-1043
13. Gressner A.M., and Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 10 (2006) 76-99
14. Gui S.Y., Wei W., Wang H., Wu L., Sun W.Y., Chen W.B., and Wu C.Y. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. Journal of Ethnopharmacology 103 (2006) 154-159
15. Itoh S., and ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Current Opinion in Cell Biology 19 (2007) 176-184
16. Kershenobich D. Liver fibrosis and cirrhosis: are they reversible?. Revista de gastroenterologia de Mexico 69 Suppl. 3 (2004) 149-151
17. Kumar M., and Sarin S.K. Is cirrhosis of the liver reversible?. Indian Journal of Pediatrics 74 (2007) 393-399
18. Lee Y.S., Han O.K., Park C.W., Suh S.I., Shin S.W., Yang C.H., Jeon T.W., Lee E.S., Kim K.J., Kim S.H., Yoo W.K., and Kim H.J. Immunomodulatory effects of aqueous-extracted Astragali radix in methotrexate-treated mouse spleen cells. Journal of Ethnopharmacology 84 (2003) 193-198
19. Li C., Luo J., Li L., Cheng M., Huang N., Liu J., and Waalkes M.P. Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmaceutica Sinica 24 (2003) 230-234
20. Li C., Luo J., Li L., Cheng M., Huang N., Liu J., and Waalkes M.P. The collagenolytic effects of the traditional Chinese medicine preparation, Han-Dan-Gan-Le, contribute to reversal of chemical-induced liver fibrosis in rats. Life Sciences 72 (2003) 1563-1571
21. Li X., He D., Zhang L., Cheng X., Sheng B., and Luo Y. A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits. Urological Research 34 (2006) 277-282
22. Matsuoka M., Pham N.T., and Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9 (1989) 71-78
23. Moustakas A., Souchelnytskyi S., and Heldin C.H. Smad regulation in TGF-beta signal transduction. Journal of Cell Science 114 (2001) 4359-4369
24. Nikolaidis N., Kountouras J., Giouleme O., Tzarou V., Chatzizisi O., Patsiaoura K., Papageorgiou A., Leontsini M., Eugenidis N., and Zamboulis C. Colchicine treatment of liver fibrosis. Hepatogastroenterology 53 (2006) 281-285
25. Pinzani M., Gesualdo L., Sabbah G.M., and Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. The Journal of Clinical Investigation 84 (1989) 1786-1793
26. Ramos S.G., Montenegro A.P., Goissis G., and Rossi M.A. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathology International 44 (1994) 655-661
27. Stickel F., and Schuppan D. Herbal medicine in the treatment of liver diseases. Digestive and Liver Disease 39 (2007) 293-304
28. Sugawara H., Ueno T., Torimura T., Inuzuka S., and Tanikawa K. Inhibitory effect of OPC-15161, a component of fungus Thielavia minor, on proliferation and extracellular matrix production of rat cultured hepatic stellate cells. Journal of Cellular Physiology 174 (1998) 398-406
29. Tsukamoto H., Matsuoka M., and French S.W. Experimental models of hepatic fibrosis: a review. Seminars in Liver Disease 10 (1990) 56-65
30. Xu H.D., You C.G., Zhang R.L., Gao P., and Wang Z.R. Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages. The Journal of International Medical Research 5 (2007) 84-90
31. Yang Q., Lu J.T., Zhou A.W., Wang B., He G.W., and Chen M.Z. Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacologica Sinica 22 (2001) 809-812